
X
Vectura seeks new CEO as Ward-Lilley steps down
https://pharmaphorum.com/news/vectura-seeks-new-ceo-as-ward-lilley-steps-down/
GlaxoSmithKline could be poised to acquire its respiratory partner, UK biotech Vectura, for $1.65bn.
Firms extend existing respiratory deal.
EU filing plans halted after phase 3 setback.